Skip to main content
. Author manuscript; available in PMC: 2016 Nov 29.
Published in final edited form as: Neuromuscul Disord. 2007 Apr 5;17(6):443–450. doi: 10.1016/j.nmd.2007.02.009

Fig. 3.

Fig. 3

Serial consecutive sections showing strong desmin (A), αB-crystallin (B), dystrophin (C) and γ-filamin (D) immunoreactivity, and weak myotilin (E), and ubiquitin (F) immunoreactivity.